Astellas Pharma
Stock
Stock
ISIN: JP3942400007
Ticker: 4503
JP3942400007
4503
Price
Price
Historical dividends and forecast
Astellas Pharma has so far distributed $0.224 in 2024. The next dividend will be paid on 02.12.2024
$0.224
CHART BY
Frequently asked questions
What is Astellas Pharma's market capitalization?
The market capitalization of Astellas Pharma is $18.26B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Astellas Pharma's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Astellas Pharma is 51.35. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Astellas Pharma?
Astellas Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.197. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Astellas Pharma's stock?
Currently, 14 analysts cover Astellas Pharma's stock, with a consensus target price of $12.63. Analyst ratings provide insights into the stock's expected performance.
What is Astellas Pharma's revenue over the trailing twelve months?
Over the trailing twelve months, Astellas Pharma reported a revenue of $11.45B.
Is Astellas Pharma paying dividends?
Yes, Astellas Pharma is paying dividends. The next payment is scheduled for 02.12.2024, with an expected amount of .
What is the EBITDA for Astellas Pharma?
Astellas Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $2.04B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Astellas Pharma?
Astellas Pharma has a free cash flow of -$6.99M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the 5-year beta of Astellas Pharma's stock?
The 5-year beta for Astellas Pharma is 0.62. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.
How many employees does Astellas Pharma have, and what sector and industry does it belong to?
Astellas Pharma employs approximately 14,754 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.
What is the free float of Astellas Pharma's shares?
The free float of Astellas Pharma is 1.79B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
Market Cap
$18.26B5Y beta
0.62EPS (TTM)
$0.197Free Float
1.79BP/E ratio (TTM)
51.35Revenue (TTM)
$11.45BEBITDA (TTM)
$2.04BFree Cashflow (TTM)
-$6.99MPricing
1D span
$10.07$10.18
52W span
$9.908$15.68
Analyst Ratings
The price target is $12.63 and the stock is covered by 14 analysts.
Buy
9
Hold
4
Sell
1
Information
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
14,754
Biotechnology & Drugs
Health Care
Identifier
ISIN
JP3942400007
Primary Ticker
4503